AMPK/mTOR modulator-1

AMPK/mTOR modulator-1 是一种人参皂苷衍生物,作为具有口服活性的 mTOR 抑制剂和 AMPK 激活剂,其激活 AMPK 信号通路的 Kd 值为 4.759 μM,可促进 M1 型肿瘤相关巨噬细胞极化并抑制 M2 型极化、增强糖酵解,从而显著抑制肿瘤进展并表现出抗炎活性,可用于结直肠癌研究。
产品编号: MS-Q75205 CAS No.: 1190602-80-2 分子式: C31H56O4 分子量: 492.77
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
50mg
询价
询价
100mg
询价
询价
250mg
询价
询价

产品描述

AMPK/mTOR modulator-1 是一种人参皂苷衍生物,作为具有口服活性的 mTOR 抑制剂和 AMPK 激活剂,其激活 AMPK 信号通路的 Kd 值为 4.759 μM,可促进 M1 型肿瘤相关巨噬细胞极化并抑制 M2 型极化、增强糖酵解,从而显著抑制肿瘤进展并表现出抗炎活性,可用于结直肠癌研究。

生物实验数据

生物活性 AMPK/mTOR modulator-1, a ginsenoside derivative, is an orally active mTOR inhibitor and AMPK activator that activates the AMPK signaling pathway with a Kd value of 4.759 μM, promotes M1-type tumor-associated macrophage polarization while inhibiting M2-type polarization, enhances glycolysis, and significantly suppresses tumor progression with anti-inflammatory activity, making it applicable for colorectal cancer research.
IC50 & Target AMPK:4.759 μM (Kd)
体外研究
(In Vitro)

AMPK/mTOR modulator-1 (Compound AD-1) 可直接与重组 AMPK 蛋白结合,其 Kd 值为 4.759 × 10−6 M。
AMPK/mTOR modulator-1 (2.5-10 μM;24 h) 以剂量依赖的方式促进 RAW264.7 来源肿瘤相关巨噬细胞 (TAMs) 向 M1 样极化,并抑制其向 M2 样极化。
AMPK/mTOR modulator-1 (2.5-10 μM;24 h) 以剂量依赖方式激活 AMPK 并抑制 RAW264.7 来源肿瘤相关巨噬细胞 (TAMs) 中的 mTOR 信号通路。
AMPK/mTOR modulator-1 (2.5-10 μM;24 h) 以剂量依赖的方式增强 RAW264.7 来源的 TAM 的糖酵解活性。

RT-PCR

Cell Line: RAW264.7-derived TAMs in TCS of mouse colon cancer cells (CT26)
Concentration: 2.5, 5, and 10 μM
Incubation Time: 24 h
Result: Downregulated M2 -associated markers (Arg-1, IL-10, and TGF-β)
and upregulated M1-associated markers (iNOS, TNF-α, and IL-1β).

Western Blot Analysis

Cell Line: RAW264.7-derived TAMs in TCS of mouse colon cancer cells (CT26)
Concentration: 2.5, 5, and 10 μM
Incubation Time: 24 h
Result: Increased protein levels of iNOS and reduced Arg-1 levels.
Increased P-AMPK AMPK ratio and reduced p-mTOR/mTOR ratio.
Upregulated the expression of key glycolytic en-zymes, including GLUT1, LDHA, PKM2, and HK2.

ELISA Assay

Cell Line: RAW264.7-derived TAMs in TCS of mouse colon cancer cells (CT26)
Concentration: 2.5, 5, and 10 μM
Incubation Time: 24 h
Result: Reduced TGF-β, IL-10 levles and increased IL-1β, TNF-α levels.
体内研究
(In Vivo)

AMPK/mTOR modulator-1 (Compound AD-1) (10 mg/kg;灌胃给药;每日 1 次;持续 64 天) 在 AOM (MS-I63952)/DSS (MS-A45736) 诱导的 CAC 小鼠中可通过促进 M1 样极化,并抑制 M2 样极化抑制结肠炎相关肿瘤的发生发展。
AMPK/mTOR modulator-1 (10 mg/kg;灌胃给药;每日 1 次;连续 15 天) 在 HT-29 细胞异种移植小鼠中可抑制肿瘤生长并重编程 TAM 极化。

Animal Model: CAC mice induced by AOM/DSS (male, BALB/c, 6–8 weeks old, 20–22 g)
Dosage: 10 mg/kg
Administration: oral gavage; daily; 64 days
Result: Restored colon length and reduced tumor number.
Alleviated crypt destruction, epithelial damage, and inflammatory infiltration.
Decreased Ki-67-positive proliferating cells and reduced proportion of F4/80+CD206+ (M2-like) TAMs.
Increased levels of TNF-α and IL-1β and decreased IL-10 levels.
Increased iNOS protein levels and decreased Arg-1 protein levels.
Increased infiltration of F4/80+CD86+ (M1-like) TAMs and decreased F4/80+CD206+ TAMs in colonic tissues.
Animal Model: CRC mice with HT-29 cells xenograft (female, BALB/c nude, 6–8 weeks old, 20–22 g)
Dosage: 10 mg/kg
Administration: oral gavage; daily; 15 days
Result: Reduced tumor volume and weight, inflammatory cell infiltration and improved tissue architecture in tumor sections.
Decreased tumor cell proliferation (lower Ki-67 expression).
Elevated iNOS expression and decreased Arg-1 expression.
Increased abundance of F4/80+CD86+ (M1-like) TAMs; reduced number of F4/80+CD206+ (M2-like) TAMs in tumor tissue.

化学信息

分子量 492.77
分子式 C31H56O4
CAS No. 1190602-80-2

储存&溶解度

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

运输条件 Room temperature in continental US; may vary elsewhere.

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础